ASX: APC · Five-year financial review

(ASX: APC) APC Minerals Financial Review - FY2021~25

This is not a smooth five-year growth story. APC’s Lake Wells potash investment was followed by a large impairment and voluntary administration, before the company returned to a smaller exploration portfolio. The FY2024 profit mainly reflects the restructuring outcome, not a producing mine’s recovery.

Years ended 30 June 2021-2025 · consolidated Australian-dollar statements · historical Australian Potash period included · Editorial review: 2026-09-28 · MII Research

Reading the figures: Units are stated above each table or beside the metric. Brackets denote negative amounts. Supported nil is shown as zero; unlike reporting bases remain separately labelled.

FY2025 cash
A$0.580m

Below the prior year-end balance.

FY2025 loss
A$2.439m

After FY2024 restructuring profit.

FY2025 equity
A$0.388m

Positive but a much smaller base.

FY2023 impairment
A$37.761m

Non-recurring earnings charge.

Five years in context

Early spending targeted the Lake Wells Sulphate of Potash development. Public funding decisions and conditional facilities were financing steps, not evidence that the full amounts had been drawn or the project had entered commercial production.

After the unsuccessful funding process, the potash tenure was surrendered and camp assets sold. The subsequent focus shifted toward Nexus and Lake Wells gold exploration; the gold and potash projects must not be treated as the same continuing operating asset.

Events behind the numbers

FY2021

Lake Wells development preparation

Accommodation facilities were completed and borefield drilling mobilisation began. NAIF and conditional EFA financing steps did not themselves constitute cash drawdowns.

FY2022

Funding remained the construction condition

The project was described as pre-construction with design and approvals advanced, but sufficient equity funding had not been achieved.

FY2023

Large project impairment

Exploration carrying value was impaired to the recoverable camp-sale amount. The strategic funding failure and surrender decision were announced in August 2023 after year-end.

FY2024

Administration, DOCA and reset

Voluntary administration began in December 2023; control returned to directors in February 2024 after the DOCA process. Tenure surrender, rehabilitation and asset sales closed the potash phase.

FY2025

New exploration acreage; funding still needed

GMG was acquired in July 2024, adding contiguous Nexus holdings. Resource-linked contingent milestones were not provisioned because they had not been met and were not considered probable.

FINANCIAL REVIEW / 01

Financing and cash use after the reset

FY2025 operating cash use was lower than in FY2024, but funding did not fully cover operating and investing outflows. The going-concern disclosure still relied on a near-term equity raising.

Closing cash

A$ million

Closing cashClosing cash: FY2021 7.797; FY2022 0.879; FY2023 1.292; FY2024 1.198; FY2025 0.58002.184.376.558.73FY2021FY2022FY2023FY2024FY2025Closing cash, FY2021: 7.797 A$ million7.797Closing cash, FY2022: 0.879 A$ million0.879Closing cash, FY2023: 1.292 A$ million1.292Closing cash, FY2024: 1.198 A$ million1.198Closing cash, FY2025: 0.580 A$ million0.580
Closing cash
Cash balances; conditional project finance is excluded.

AI-generated presentation · values from Financial history across a major restructuring; no missing values plotted as zero.

Operating cash and financing

A$ million

Operating cash and financingOperating cash flow: FY2021 (3.031); FY2022 (3.890); FY2023 (3.106); FY2024 (3.039); FY2025 (2.188) | Financing cash flow: FY2021 15.913; FY2022 14.389; FY2023 6.254; FY2024 1.887; FY2025 1.613-5.080.766.6112.4518.29FY2021FY2022FY2023FY2024FY2025Operating cash flow, FY2021: (3.031) A$ millionOperating cash flow, FY2022: (3.890) A$ millionOperating cash flow, FY2023: (3.106) A$ millionOperating cash flow, FY2024: (3.039) A$ millionOperating cash flow, FY2025: (2.188) A$ millionFinancing cash flow, FY2021: 15.913 A$ millionFinancing cash flow, FY2022: 14.389 A$ millionFinancing cash flow, FY2023: 6.254 A$ millionFinancing cash flow, FY2024: 1.887 A$ millionFinancing cash flow, FY2025: 1.613 A$ million
Operating cash flowFinancing cash flow
The operating line excludes exploration classified as investing.

AI-generated presentation · values from Financial history across a major restructuring; no missing values plotted as zero.

Financial history across a major restructuring

A$ million

MetricFY2021FY2022FY2023FY2024FY2025
Profit / (loss) after tax(3.734)(5.579)(41.606)0.477(2.439)
Operating cash flow(3.031)(3.890)(3.106)(3.039)(2.188)
Investing cash flow(8.462)(17.432)(2.736)1.055(0.043)
Financing cash flow15.91314.3896.2541.8871.613
Closing cash7.7970.8791.2921.1980.580

Years ended 30 June; A$ million. Historical issuer name Australian Potash is part of the same selected company history.

FY2024 investing cash is positive despite the extracted row caption saying outflows; asset-sale receipts establish the inflow.

FY2023 impairment and FY2024 administration gain make simple profit growth comparisons misleading.

Source: Annual-report extractions; report editions are listed once in the consolidated source registry.

FINANCIAL REVIEW / 02

The FY2024 profit was a restructuring result

The administration gain exceeded the reported FY2024 profit. It should not be annualised as a recurring return, just as the FY2023 impairment should not be equated with that year’s cash spending.

Impairment and administration gain

A$ million

Impairment and administration gainImpairment expense: FY2023 (37.761); FY2024 0.000 | Gain on voluntary administration: FY2023 0.000; FY2024 3.690-40.25-28.02-15.79-3.568.66FY2023FY2024Impairment expense, FY2023: (37.761) A$ millionImpairment expense, FY2024: 0.000 A$ millionGain on voluntary administration, FY2023: 0.000 A$ millionGain on voluntary administration, FY2024: 3.690 A$ million
Impairment expenseGain on voluntary administration
Two different accounting events, not a cash flow series.

AI-generated presentation · values from Two non-recurring accounting events; no missing values plotted as zero.

Two non-recurring accounting events

A$ million

MetricFY2023FY2024
Impairment expense(37.761)0.000
Gain on voluntary administration0.0003.690

These are income-statement items, not same-period cash outflows/inflows of identical amounts.

The FY2024 administration gain should not be interpreted as recurring operating profit.

Source: Annual-report extractions; report editions are listed once in the consolidated source registry.

FINANCIAL REVIEW / 03

The type and scale of project spending changed

The decline in investing exploration cash reflects the end of the earlier development programme and a changed expense mix. Continuing operating exploration payments remain visible rather than being hidden by a nil investing line.

Operating versus investing exploration cash

A$ million

Operating versus investing exploration cashExploration payments within operating: FY2021 (0.370); FY2022 (0.321); FY2023 (0.261); FY2024 (1.287); FY2025 (1.093) | Evaluation/exploration payments within investing: FY2021 (8.342); FY2022 (17.260); FY2023 (2.823); FY2024 0.000; FY2025 (0.033)-18.3-13.2-8.11-3.022.07FY2021FY2022FY2023FY2024FY2025Exploration payments within operating, FY2021: (0.370) A$ millionExploration payments within operating, FY2022: (0.321) A$ millionExploration payments within operating, FY2023: (0.261) A$ millionExploration payments within operating, FY2024: (1.287) A$ millionExploration payments within operating, FY2025: (1.093) A$ millionEvaluation/exploration payments within investing, FY2021: (8.342) A$ millionEvaluation/exploration payments within investing, FY2022: (17.260) A$ millionEvaluation/exploration payments within investing, FY2023: (2.823) A$ millionEvaluation/exploration payments within investing, FY2024: 0.000 A$ millionEvaluation/exploration payments within investing, FY2025: (0.033) A$ million
Exploration payments within operatingEvaluation/exploration payments within investing
Separate cash classifications; both are negative payments.

AI-generated presentation · values from Exploration cash moved from development investment to operating expense; no missing values plotted as zero.

Exploration cash moved from development investment to operating expense

A$ million

MetricFY2021FY2022FY2023FY2024FY2025
Exploration payments within operating(0.370)(0.321)(0.261)(1.287)(1.093)
Evaluation/exploration payments within investing(8.342)(17.260)(2.823)0.000(0.033)

These cash lines are already included in the totals above. They are not an extra deduction.

Nil investing exploration in FY2024 does not mean no exploration activity: operating exploration payments continued.

Source: Annual-report extractions; report editions are listed once in the consolidated source registry.

Historical exploration asset carrying values

A$ million

MetricFY2021FY2022FY2023FY2024
Exploration and evaluation20.82335.7630.9500.000

The FY2023 remaining balance represented the recoverable camp-sale value after impairment. Sale completed during FY2024.

FY2025 detailed exploration carrying value is not supplied in this packet; it is not assumed zero from the prior-year nil.

Source: Annual-report extractions; report editions are listed once in the consolidated source registry.

FINANCIAL REVIEW / 04

Positive equity returned on a much smaller asset base

Impairment produced a FY2023 equity deficiency. The subsequent recapitalisation and administration process restored positive equity, but FY2025 losses reduced the remaining buffer. Positive working capital does not remove the stated funding uncertainty.

Equity / deficiency

A$ million

Equity / deficiencyEquity / (deficiency): FY2021 23.961; FY2022 33.031; FY2023 (2.561); FY2024 0.746; FY2025 0.388-4.75.816.326.837.3FY2021FY2022FY2023FY2024FY2025Equity / (deficiency), FY2021: 23.961 A$ million23.961Equity / (deficiency), FY2022: 33.031 A$ million33.031Equity / (deficiency), FY2023: (2.561) A$ million(2.561)Equity / (deficiency), FY2024: 0.746 A$ million0.746Equity / (deficiency), FY2025: 0.388 A$ million0.388
Equity / (deficiency)
Historical continuity includes a major restructuring; not like-for-like mine performance.

AI-generated presentation · values from The balance sheet after impairment and recapitalisation; no missing values plotted as zero.

The balance sheet after impairment and recapitalisation

A$ million

MetricFY2021FY2022FY2023FY2024FY2025
Total assets29.69937.6502.9621.5600.783
Total liabilities5.7384.6205.5230.8140.395
Equity / (deficiency)23.96133.031(2.561)0.7460.388
Working capital / (deficit)2.883(2.527)(3.790)0.6400.303

FY2025 total assets are calculated as total equity plus total liabilities from extracted consolidated figures; other total-asset cells are reported.

Working capital is current assets less current liabilities, not an estimate of future funding runway.

Source: Annual-report extractions; report editions are listed once in the consolidated source registry.

FINANCIAL REVIEW / 05

Equity cash is not the whole financing story

Cash received from convertible debt in FY2025 is shown as a financing inflow, without assuming that the same amount remained outstanding at year-end. The frozen packet does not fully explain the conversion/carrying-value reconciliation, so no unsupported debt roll-forward is added.

Equity cash funding

A$ million

MetricFY2021FY2022FY2023FY2024FY2025
Share and option proceeds17.06415.4746.4433.0011.433
Cash share-issue costs(1.056)(0.902)(0.189)(0.229)(0.320)

FY2024 additionally includes A$0.884m paid to the administrator within financing.

FY2025 additionally includes A$0.500m of convertible-debt receipts. Neither is included in the share proceeds row.

Source: Annual-report extractions; report editions are listed once in the consolidated source registry.

Reading the figures

  • Frozen annual extraction only; no original reports, new DB retrieval, financial web research or MiniMax drafting. Published primary-author-reviewed copy.
  • The FY2023/FY2024 reset changes business and accounting comparability. A single growth rate across these years would obscure impairment, tenure surrender and administration.
  • A FY2023 note paraphrase places surrender at balance date; the explicitly dated August announcement and October completion are used for the event timeline while the impairment remains in FY2023.
  • The FY2025 detailed exploration asset and convertible-note reconciliation are not supplied adequately. The report retains cash receipts and group totals without inventing missing debt or asset detail.
  • The GMG resource-linked milestones are contingent; no mineral resource achievement or future payment is assumed.

Annual-report source registry

  • APC Minerals / Australian Potash - Annual Report to shareholdersFrozen annual extraction; restructuring and event timing retained.
  • APC Minerals / Australian Potash - Annual Report to shareholdersFrozen annual extraction; restructuring and event timing retained.
  • APC Minerals / Australian Potash - Annual Report to shareholdersFrozen annual extraction; restructuring and event timing retained.
  • APC Minerals / Australian Potash - Annual Report to shareholdersFrozen annual extraction; restructuring and event timing retained.
  • APC Minerals / Australian Potash - Annual Report to shareholdersFrozen annual extraction; restructuring and event timing retained.

Prepared solely from the existing year-by-year extraction datasets. No raw annual-report body, PDF, new database lookup or financial web research was used. Review is against those stored extractions, not a new independent original-document audit.

Sources, copyright and independence

The source references in this report identify the public disclosures used and should be read with the associated section, table and reporting-period qualifications. This report paraphrases, organises and compares those disclosures for descriptive and educational purposes rather than reproducing source text.

Copyright and other rights in linked reports, company names, logos and third-party materials remain with their respective owners. MII Research does not claim affiliation with or endorsement by the company covered in this report, the ASX or cited organisations.

AI-led method

This report uses AI actively and extensively for evidence extraction, comparison, organisation, calculation checks, drafting, translation planning and presentation. Material claims received reasonable editorial review against cited public sources; this was not an audit, assurance engagement or independent verification. Limitations in public sources, AI systems and review may leave errors, omissions, inconsistencies or translation, classification and interpretation errors.

Any AI-generated visual accompanying this report must carry an adjacent, visible AI-generated label or caption. Such visuals are illustrative rather than source evidence and do not replace the cited annual-report text, table or section source.

Information notice

This record is for general descriptive and educational information only. It is not financial-product, investment, legal, tax, technical or other professional advice; it is not a securities recommendation, valuation, target price, offer, solicitation or invitation to buy, sell or hold.

It does not consider any reader’s objectives, financial situation, needs, knowledge, experience or risk tolerance. Independently verify material information against the primary disclosures, obtain appropriate independent professional advice and do not use this record as the sole or primary basis for any decision.

Public sources are used in good faith, but no representation or warranty is made as to accuracy, completeness, reliability, currency or fitness for a particular purpose. To the maximum extent permitted by law, MII Research disclaims liability for direct, indirect, incidental, consequential, opportunity or investment loss arising from use of or reliance on this record; nothing excludes or limits liability that cannot lawfully be excluded or limited.

Report suspected errors to MII Research with the relevant report section and primary-source document and page reference so that the record can be reviewed and corrected where appropriate.